These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2314363)

  • 1. Neurobehavioral effects of the pyridinium aldoxime cholinesterase reactivator HI-6.
    Liu WF; Shih JH
    Neurotoxicol Teratol; 1990; 12(1):73-8. PubMed ID: 2314363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral toxicological assessment of oral pralidoxime methanesulfonate in the rat.
    Liu WF; Hu NW; Beaton JM
    Neurobehav Toxicol Teratol; 1984; 6(2):121-7. PubMed ID: 6472556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neurobehavioral effects of pralidoxime mesylate in the rat.
    Liu WF; Beaton JM
    Neurobehav Toxicol Teratol; 1985; 7(5):449-52. PubMed ID: 4080064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral comparison of the oximes TMB-4, 2-PAM, and HI-6 in rats using operant conditioning.
    Genovese RF; Doctor BP
    Pharmacol Biochem Behav; 1997 Jan; 56(1):139-43. PubMed ID: 8981621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The acetylcholinesterase reactivator HI-6 (1-[[[4-(aminocarbonyl)pyridinio]methoxyl]methyl]- 2-[(hydroxyimino)methyl]-pyridinium dichloride): a comparative study of HI-6 samples from various sources.
    Clement JG; Lockwood PA; Thompson HG
    Arch Toxicol; 1988; 62(2-3):220-3. PubMed ID: 3196157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of acetylcholinesterase reactivators on selected hepatic functions in rats.
    Pejchal J; Osterreicher J; Kuca K; Jun D; Bajgar J; Kassa J
    Basic Clin Pharmacol Toxicol; 2008 Aug; 103(2):119-23. PubMed ID: 18816293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditioned effects produced by naltrexone doses that reduce ethanol-reinforced responding in rhesus monkeys.
    Williams KL; Woods JH
    Alcohol Clin Exp Res; 1999 Apr; 23(4):708-15. PubMed ID: 10235307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic toxicology assessment of HI-6 dichloride.
    Putman D; San RH; Bigger CA; Levine BS; Jacobson-Kram D
    Environ Mol Mutagen; 1996; 27(2):152-61. PubMed ID: 8603667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditioned taste aversion induced by organophosphate compounds in rats.
    Roney PL; Costa LG; Murphy SD
    Pharmacol Biochem Behav; 1986 Mar; 24(3):737-42. PubMed ID: 3703907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the radioprotector WR-2721 on operant behavior in the rat.
    Liu WF; Shih JH; Lee JD; Ma C; Lee SF; Lin CH
    Neurotoxicol Teratol; 1989; 11(3):199-204. PubMed ID: 2547148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral, Pharmacokinetic, and Cardiovascular Evaluation of Candidate Oximes in African Green Monkeys.
    Moffett MC; McDonough JH; McMonagle JD; Myers TM
    Int J Toxicol; 2018; 37(5):352-363. PubMed ID: 29879849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of two metabolites of the cholinesterase reactivator HI-6 isolated from rat urine.
    Ligtenstein DA; Wils ER; Kossen SP; Hulst AG
    J Pharm Pharmacol; 1987 Jan; 39(1):17-23. PubMed ID: 2880978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse behavioral effects of the anticholinesterase poisoning protector pralidoxime methanesulfonate.
    Liu WF; Hu NW; Chian TF; Ma C; Lin CH; Liu CY; Wu MT
    Proc Natl Sci Counc Repub China B; 1984 Oct; 8(4):341-6. PubMed ID: 6571596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of several oximes on reactivation of soman-inhibited blood, brain and tissue cholinesterase activity in rats.
    Shih TM
    Arch Toxicol; 1993; 67(9):637-46. PubMed ID: 8311691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral effects of arginine in male rats.
    Drago F; Continella G; Alloro MC; Auditore S; Pennisi G
    Pharmacol Res Commun; 1984 Sep; 16(9):899-907. PubMed ID: 6504972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
    Kassa J; Karasova J; Musilek K; Kuca K; Bajgar J
    Clin Toxicol (Phila); 2009 Jan; 47(1):72-6. PubMed ID: 18686075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of behavioural responses to an ACTH analog in CXB/By recombinant inbred mice.
    Crabbe JC; Rigter H; Kerbusch S
    Behav Brain Res; 1982 Mar; 4(3):289-314. PubMed ID: 6277349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide dose dependently impairs rapid toxin (LiCl)-induced gustatory conditioning: a taste reactivity examination of the conditioned taste aversion.
    Cross-Mellor SK; Foley KA; Parker LA; Ossenkopp KP
    Brain Behav Immun; 2009 Feb; 23(2):204-16. PubMed ID: 18835436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the potency of newly developed oximes (K027, K048) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats.
    Kassa J; Kunesova G
    J Appl Toxicol; 2006; 26(4):309-16. PubMed ID: 16552727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal and qualitative dynamics of conditioned taste aversion processing: combined generalization testing and licking microstructure analysis.
    Baird JP; St John SJ; Nguyen EA
    Behav Neurosci; 2005 Aug; 119(4):983-1003. PubMed ID: 16187827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.